Conventional radiotherapy and intensity-modulated radiotherapy in carcinoma vulva: An experience from a tertiary medical center of India

被引:10
作者
Mazumder, Koustav [1 ]
Elangovan, Arun [1 ]
Rai, Bhavana [1 ]
Suri, Vanita [2 ]
Jain, Vanita [2 ]
Kalra, Jaswinder [2 ]
Ghoshal, Sushmita [1 ]
机构
[1] Postgrad Med Educ & Res, Dept Radiotherapy & Oncol, Chandigarh, India
[2] Postgrad Med Educ & Res, Dept Gynecol & Obstet, Chandigarh, India
关键词
Radiotherapy; cancer; vulva; DOSIMETRIC EVALUATION; CANCER;
D O I
10.4103/sajc.sajc_66_17
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: Vulvar cancer is one of the uncommon gynecological malignancies. Multimodality treatment with surgery, radiotherapy, and chemotherapy are required for treatment of the disease. Aims: The aim of the study was to evaluate clinical outcome in patients of carcinoma vulva, treated at our institution. Subjects and Methods: This was a retrospective-cohort study done in 50 patients with squamous cell carcinoma of the vulva, treated at our institution from January 2008 to December 2014. Data were analyzed on the basis of age, stage, type of treatment received, and treatment-related toxicity. Disease-free survival and overall survival were estimated. Statistical Analysis Used: Kaplan-Meier survival analysis and Chi-square test were used for statistical analysis. Results: Majority of the patients (52%) had presented with Stage III disease. Thirty-six of 50 patients underwent surgery: simple vulvectomy - 2, radical vulvectomy - 34, bilateral inguinal lymph node dissection was done in 32 patients, and 1 patient underwent ipsilateral-inguinal lymph node dissection. Among 40 patients who received radiotherapy and eight patients received palliative radiotherapy. Seventeen patients underwent intensity-modulated radiotherapy (IMRT) and 15 patients received conventional radiotherapy. Significantly less Grade 2 or more skin toxicity (P = 0.003) observed in patients who underwent IMRT. Among non-IMRT group, eight patients required treatment break during radiation. At a median follow-up time of 25.5 months, median overall survival was 31 months and median disease-free survival was 25 months. About 42% patients were alive and free of disease at last follow-up. Conclusions: Modified radical vulvectomy with inguinal lymph node dissection followed by radiotherapy is the mainstay of management of locally advanced carcinoma vulva. Using IMRT, we could minimize the treatment related radiation toxicity and treatment breaks.
引用
收藏
页码:41 / 43
页数:3
相关论文
共 50 条
[41]   Experience with intensity-modulated radiotherapy in the treatment of head and neck cancer [J].
Vanasek, J. ;
Odrazka, K. ;
Dusek, L. ;
Jarkovsky, J. ;
Michalek, R. ;
Chrobok, V. ;
Dolezel, M. ;
Kolarova, I. .
JOURNAL OF BUON, 2013, 18 (04) :970-976
[42]   Results and prognostic factors of 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for esophageal carcinoma [J].
Tan, L. ;
Xiao, Z. ;
Zhang, H. ;
Chen, D. ;
Feng, Q. ;
Zhou, Z. ;
Lv, J. ;
Liang, J. ;
Hui, Z. ;
Wang, L. ;
Yin, W. .
NEOPLASMA, 2015, 62 (05) :777-786
[43]   Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma [J].
Xiayun, He ;
Ou, Dan ;
Ying, Hongmei ;
Zhu, Guopei ;
Hu, Chaosu ;
Liu, Taifu .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2012, 269 (03) :1027-1033
[44]   Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study [J].
Wang Lan ;
Liu Lihong ;
Han Chun ;
Liu Shutang ;
Wang Qi ;
Xu Liang ;
Li Xiaoning ;
Liu Likun .
STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (09) :802-811
[45]   Comparison of Failure Patterns Between Conventional and Intensity-modulated Radiotherapy for Stage III and IV Head and Neck Squamous Cell Carcinoma [J].
Song, Jin Ho ;
Jeong, Bae-Kwon ;
Choi, Hoon-Sik ;
Jeong, Hojin ;
Kang, Myoung Hee ;
Kang, Jung Hun ;
Kim, Jin Pyeong ;
Park, Jung Je ;
Woo, Seung Hoon ;
Jang, Hong Seok ;
Choi, Byung Ock ;
Kang, Ki Mun .
ANTICANCER RESEARCH, 2015, 35 (12) :6833-6840
[46]   Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results [J].
Bae, Sun Hyun ;
Jang, Won Il ;
Park, Hee Chul .
ONCOTARGET, 2017, 8 (35) :59965-59976
[47]   Intensity-modulated radiotherapy for sinonasal teratocarcinosarcoma [J].
Gang Peng ;
Yang Ke ;
Tao Wang ;
Yiming Feng ;
Yuehua Li ;
Gang Wu .
Journal of Huazhong University of Science and Technology [Medical Sciences], 2011, 31 :857-860
[48]   Intensity-modulated Radiotherapy for Sinonasal Teratocarcinosarcoma [J].
彭纲 ;
柯杨 ;
王涛 ;
冯一鸣 ;
李跃华 ;
伍钢 .
Current Medical Science, 2011, (06) :857-860
[49]   EXPERIENCE-BASED QUALITY CONTROL OF CLINICAL INTENSITY-MODULATED RADIOTHERAPY PLANNING [J].
Moore, Kevin L. ;
Brame, R. Scott ;
Low, Daniel A. ;
Mutic, Sasa .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02) :545-551
[50]   Intensity-modulated radiotherapy for cushing's disease: single-center experience in 70 patients [J].
Lian, Xin ;
Xu, Zhuoran ;
Sun, Shuai ;
Wang, Weiping ;
Zhu, Huijuan ;
Lu, Lin ;
Hou, Xiaorong ;
Zhang, Fuquan .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14